University of Kentucky: 2 Postdoc Positions in Breast Cancer Research (Yadi Wu Lab)

Application Deadline: not specified in the original announcement | 2 postdoctoral positions

Positions2 postdoctoral researchers (Yadi Wu Lab, Markey Cancer Center)
UniversityUniversity of Kentucky, Markey Cancer Center
LocationLexington, Kentucky, USA
Funding & SalaryNot specified; the announcement states that salary, benefits and the formal application procedure follow the university recruitment notice and subsequent communication
Start DateNot specified
Application DeadlineNot specified
How to ApplySend an English-language CV (education, research experience and publication list) to [email protected]; suggested subject line “Postdoctoral Application – Name”


Scholarship Description:

The Yadi Wu Lab at the Markey Cancer Center of the University of Kentucky is recruiting two postdoctoral researchers to work on mechanisms of breast cancer progression, with a focus on immune evasion, interactions between the nervous system and the tumour microenvironment, and therapy resistance. The announcement welcomes physicians with clinical experience in breast cancer diagnosis and treatment, as well as early-career scholars with a background in molecular and cell biology, pharmacology, immunology or related disciplines.

According to the announcement, the lab has long focused on breast cancer research, particularly tumour metastasis, metabolism, immune evasion and epigenetic regulation. It combines conditional gene knockout mice, patient-derived xenograft (PDX) models and patient-derived organoids (PDO) with ChIP-seq, ATAC-seq, CUT&RUN and single-cell RNA sequencing (scRNA-seq) to study breast cancer progression and treatment resistance.

The University of Kentucky was founded in 1865 and is located in Lexington, Kentucky. The announcement describes it as the state’s flagship public research university and an R1 research university in the Carnegie Classification. The Markey Cancer Center is described as the university’s cancer research and clinical treatment institution. The announcement also notes that Lexington is known as the “Horse Capital of the World”, with a pleasant environment, good public safety, convenient transport and amenities, a relatively low cost of living and a local Chinese community.


Available Subjects:

  • Molecular mechanisms of immune evasion in triple-negative breast cancer.
  • Interactions between the nervous system, the immune system and the tumour microenvironment.
  • Epigenetic regulation of breast cancer therapy resistance.
  • Tumour metastasis, metabolism and epigenetic regulation; conditional knockout mouse models, PDX and PDO models, ChIP-seq, ATAC-seq, CUT&RUN and scRNA-seq.

Eligibility criteria:

  • A PhD already awarded or about to be awarded in biology, biochemistry, immunology or a related field.
  • Solid experimental research skills and the ability to read and understand English-language scientific literature independently.
  • Careful and meticulous work, with attention to experimental records and data quality.
  • The announcement additionally welcomes physicians with clinical experience in breast cancer diagnosis and treatment, and early-career scholars with backgrounds in molecular and cell biology, pharmacology or immunology.
  • No English-language test score, GRE requirement, age limit, salary figure or application deadline is given in the announcement.

Application Procedure:

Send an English-language CV, including education background, research experience and a list of publications, to [email protected]. The announcement suggests the email subject “Postdoctoral Application – Name”.

The announcement states that salary, benefits and the formal application procedure follow the university recruitment notice and subsequent communication. No application deadline, start date or funding figure is specified.


Explore More Funded Opportunities: